Revlimid, Bendamustine and Prednisolone (RBP) in relapsed/refractory multiple myeloma: final results of a phase II clinical trial OSHO - #077

HAEMATOLOGICA(2016)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要